Evaluation of potential drug interactions in antimicrobial prescriptions in a hospital.

Main Article Content

Samara de Oliveira Vilaça https://orcid.org/0000-0002-2710-3021
Diego da Silva Santana https://orcid.org/0000-0002-2065-0073
Elizama de Sá Alves https://orcid.org/0000-0002-3444-1790
Soraia dos Santos Penha https://orcid.org/0000-0003-3907-1765
Valdicley Vieira Vale https://orcid.org/0000-0001-6570-4875
Chriscia Jamilly Pinto de Sousa https://orcid.org/0000-0002-6996-7717
Ana Cristina Lo Prete https://orcid.org/0000-0002-2874-5296
Luann Wendel Pereira de Sena
Carolina Heitmann Mares Azevedo Ribeiro https://orcid.org/0000-0002-9457-2733

Keywords

Drug interaction, Antimicrobials, Clinical pharmacist

Abstract

Background: Drug interaction is a process that occurs when the effects and/or toxicity of a drug are modified by the previous or simultaneous presence of another drug, which may result in a change in therapeutic efficacy or an increase in the risk of adverse events. Objective: to evaluate the potential drug interactions of antimicrobials in prescriptions of patients admitted to a hospital in the State of Para, in 2019. Methods: This is a qualitative-quantitative, retrospective and cross-sectional study, carried out by collecting data from medical records of patients who used antibiotics and were hospitalized in 2019 in a hospital in Para. Drug interactions were assessed using the Micromedex database. Results: During the study period, 83% (n = 762) of the patients who were admitted to the institution used antibiotics. There was a male prevalence of 54% (n = 409), the average age was 56 years. 6870 drugs were prescribed, of which 1,727 (25%) were antimicrobials, an average of two antibiotics prescribed per patient. A 52% rate (n = 395) of drug interactions was obtained between antimicrobial drugs and other classes. The drug ciprofloxacin had the highest number of interactions, 42% (n = 165), interacting with 12 different drugs. Conclusion: the prescriptions analyzed showed a high index of potential drug interactions. Thus, it is stated that the presence of the pharmaceutical professional inserted in the multiprofessional teams and in the process of evaluating prescriptions in the hospital sector, is of extreme importance and need to reduce risks and increase patient safety in the use of medications.

Abstract 88 | PDF Downloads 68

References

1. Santos JS, Giordani F, Rosa MLG. Potential drug interactions in adults and older adults in primary care. Ciência & Saúde Coletiva. 2019;24(11):4335-44. https://doi.org/10.1590/1413-812320182411.04692018
2. Alvim MM, Silva LA, Leite ICG, Silvério MS. Adverse events due to potential drug interactions in the intensive care unit of a teaching hospital. Brazilian Journal of Intensive Therapy. 2015;27(4):353-9. https://doi.org/10.5935/0103-507x.20150060
3. Celdran LMM, Ferrando JG, Royo LM. Do we know all pharmacological interactions?: the OATP1B1 transporter. Community Pharmacists. 2018;10(4):29-32.
4. Neves C, Colet C. Profile of antimicrobial use and their drug interactions in an adult ICU in Rio Grande do Sul. Journal of Epidemiology and Infection Control.2015;5(2):65-71.
5. Cortes ALB, Silvino ZR, Santos FBM, Pereira JAC, Tavares GS. Prevalence of drug interactions involving high-alert drugs: crosssectional study. Revista Mineira de Enfermagem. 2019;23:1226.
6. Brazil. Ministry of Health. Health and Foreign Policy: 20 years of the International Health Affairs Office (1998-2018). 1st ed. Brasília: Ministry of Health. 2018:364.
7. Piedade DV, Silva LAF, Lemos GS, Valasque JRGL, Lemos LB. Potential drug interactions in prescriptions containing restricted use antimicrobials for patients admitted to a hospital in the interior of Bahia. Medicine (Ribeirão Preto). 2015;48(3):295-307.
8. Brazil. Federal Council of Pharmacy. Resolution No. 585 of August 29, 2013. Regulates the clinical attributions of the pharmacist and makes other provisions. Official Gazette of the Union, Brasilia; 2013 th
9. Rodrigues AP, Dambrós BP, Santin NC, Frighetto M. Analysis of antibiotic prescriptions dispensed to children in a pharmacy in a municipality in Santa Catarina. Revista Interdisciplinar. 2017;10(4):69-76.
10. Murtaza G, Khan MY, Azhar S, Khan SA, Khan TM. (). Assessment of potential drug-drug interactions and its associated factors in the hospitalized cardiac patients. Saudi Pharmaceutical Journal. 2016;24(2):220-25.
11. Mousavi S, Ghanbari G. Potential drug-drug interactions among hospitalized patients in a developing country. Caspian Journal of Internal Medicine. 2017;8(4):282-8. https://doi.org/10.22088/cjim.8.4.282
12. Cedraz KN, Santos MC. Identification and characterization of drug interactions in medical prescriptions of the intensive care unit of a public hospital in the city of Feira de Santana, BA. Revista Sociedade Brasileira de Clínica Médica. 2014;12(2):1-7.
13. Nascimento MSM, Nunes EM, Medeiros RC, Souza WIM, Filho LFS, Alves ESRC. Epidemiological profile of patients in an adult intensive care unit of a regional hospital in Paraíba. Topics in Health. 2018;18(1):247-265.
14. Reis LCC, Gabarra LM, Moré CLOO. The repercussions of the hospitalization process in an adult ICU from the perspective of family members. Topics in Psychology. 2016;24(3):815-28.
15. Oak AMR. Analysis of the prescription of patients using an enteral tube in a university hospital in Ceará. Rev Bras Farm Hosp Serv Saúde. 2010;1(1):17-22.
16. Guia CM, Biondi RS, Sotero S, Lima AA, Almeida KJQ, Amorim FF. Epidemiological profile and predictors of mortality in a general intensive care unit of a public hospital in the Federal District. Journal of Communication in Health Sciences. 2015;26(1/2):9-19.
17. Perão O, Bub M, Zandonadi G, Martins M. Sociodemographic and epidemiological characteristics of patients admitted to an adult intensive care unit. UERJ Nursing Journal. 2017;25:7736.
18. Rodriguez AH, Bub MB, Perão OF, Zandonadi G, Rodriguez M de J. Epidemiological characteristics and causes of deaths in
hospitalized patients under intensive care. Brazilian Journal of Nursing. 2016;69(2):229-34. https://doi.org/10.1590/0034-7167.2016690204i
19. Araújo LU, Santos DF, Bodevan EC, Cruz HL, Souza J, Silva-Barcellos NM. Patient safety in primary health care and polypharmacy: cross-sectional survey among patients with chronic diseases. Latin American Journal of Nursing. 2019;27:e3217. https://doi.org/10.1590/1518-8345.3123.3217
20. Ueno E, Koffke M, Voigt VR. Profile of hospitalized patients under enteral therapy. Braspen Journal. 2018;33(2):194-8.
21. Leal LF, Cousin E, Bidinotto AB, Sganzerla D, Borges RB, Malta DC, et al. Epidemiology and burden of chronic respiratory diseases in Brazil from 1990 to 2017: analysis for the Global Burden of Disease 2017 Study. Brazilian Journal of Epidemiology. 2020;23(1):e200031. https://doi.org/10.1590/1980-549720200031
22. Vieira PN, Vieira SLV. Irrational use and antimicrobial resistance in hospitals. UNIPAR Health Science Archives. 2017;21(3):209-213.
23. Muhammed OS, Nasir BB. Drug Use Evaluation of Ceftriaxone in Ras-Desta Memorial General Hospital, Ethiopia. Drug, Healthcare and Patient Safety. 2020;12:161-8. https://doi.org/10.2147/dhps.s260364

Most read articles by the same author(s)